Advocacy intelligence hub — real-time data for patient organizations
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Patient Assistance Programs1
NAGLAZYME
BioMarin Pharmaceutical Inc.
NAGLAZYME
(GALSULFASE)Orphan drugstandardBioMarin Pharmaceutical Inc.
Browse all Mucopolysaccharidosis type 6, rapidly progressing news →
View all Mucopolysaccharidosis type 6, rapidly progressing specialists →